Format

Send to

Choose Destination
JAMA Dermatol. 2015 May;151(5):555-6. doi: 10.1001/jamadermatol.2014.5391.

Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1α, for the Treatment of Psoriasis.

Author information

1
Westlake Dermatology and Cosmetic Surgery, Austin, Texas.
2
Department of Dermatology, University of Michigan, Ann Arbor.
3
XBiotech USA, Austin, Texas.

Comment in

PMID:
25715176
DOI:
10.1001/jamadermatol.2014.5391
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center